Renovaro biosciences announces results of special meeting of shareholders

Los angeles, jan. 25, 2024 (globe newswire) -- renovaro biosciences inc. (nasdaq: renb) (the “company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the results of the company's special meeting of shareholders held at 12:00 pm et on january 25, 2024.

RENB Ratings Summary

RENB Quant Ranking